watch out for the fake posts in here.
I don't know what this person's intentions are . . yet
that posted a comment about MCT-275. There is no such study called mct-275.
This person doesn't know what he is talking about..
MultiCell Technologies is working on treatments for Cancer, Cancer tumors and Multiple Sclerosis fatigue.
Their current pipeline consists of:
MCT-125 , a Phase 2 therapeutic candidate for the treatment of PMSF which has demonstrated efficacy in a 138-patient Phase IIa clinical trial.
MCT-465 , a preclinical synthetic dsRNA therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers such as those expressing TLR-3.
MCT-475 , a discovery stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers; and
MCT-485 , a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of certain cancers.
All this is stated within their most recent 10-K published on 2/28/2013,
and their website.
MCT 275, last heard of in 2007. My google search came up with only one link. No longer even mentioned on the MCET web site. I would suggest carefully checking out each one of the patents if you really care. Good luck!